• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Drift in Molecular Testing for Influenza: Mutations Affecting Assay Performance

tetano

Editor, Senior Moderator
J Clin Microbiol. 2018 Jan 5. pii: JCM.01531-17. doi: 10.1128/JCM.01531-17. [Epub ahead of print]
[h=1]The Drift in Molecular Testing for Influenza: Mutations Affecting Assay Performance.[/h] Stellrecht KA[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza is associated with rapid evolution due to lack of RNA polymerase proofreading, immunogenic selection and frequent rearrangement of gene segments. Evolutionary changes affecting the performance of diagnostic testing have long been recognized. Hence, it is not surprising that such challenges apply to nucleic acid amplification tests, even though they are designed to target highly conserved regions. Initially, case reports involved single isolates of A(H1N1)pdm09. Over the past four years, subtype H3N2 viruses evolved to viral clades with mutations in the WHO recommended target region, such that almost all isolates worldwide have significantly reduced sensitivities with many commercial PCR tests.


PMID: 29305549 DOI: 10.1128/JCM.01531-17
 
Back
Top Bottom